A Study of The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDs

NCT01878318 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: methotrexate
DRUG: tocilizumab [RoActemra/Actemra]

Sponsor

Hoffmann-La Roche